Brief: Mina Therapeutics Enters Collaboration With Nippon Shinyaku
04/04/2024 12:07
April 4 (Reuters) - Nippon Shinyaku Co Ltd 4516.T :
* MINA THERAPEUTICS: RESEARCH COLLABORATION AND LICENSING
AGREEMENT OPTION WITH NIPPON SHINYAKU
* MINA THERAPEUTICS: COLLABORATION TO DEVELOP RNAA
THERAPEUTICS
TARGETING RARE NEURODEGENERATIVE DISEASES
* MINA THERAPEUTICS: FINANCIAL TERMS OF AGREEMENT WERE NOT
DISCLOSED
Source text for Eikon: ID:nBw3HjSB9a
Further company coverage: 4516.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)